11th Annual Medical Director/Physician Leadership Forum
Printable Schedule-at-a-Glance (Last updated: 10/09/17)
WEDNESDAY, NOV. 8, 2017
Welcome Reception (provided)
Group Dinner (provided)
THURSDAY, NOV. 9, 2017 — Up to 6.0 continuing education credits available
ACPE UAN 0860-0000-17-029-L01-P/0860-0000-17-029-L01-T (.60 CEUs)
Registration and Continental Breakfast
Welcome and Opening Remarks
Keynote Address — Closing the Gap in Health Equity, Soma Stout, MD, MS, Institute for Healthcare Improvement
In the United States, racial/ethnic minority, rural, and low-income populations continue to experience suboptimal access to and inequity of health care despite decades of recognition of health disparities and policy mandates to eliminate them. There are a number of disease states with recognized disparities and many health care interventions designed to achieve health equity fall short due to gaps in knowledge and translation. This session will address disparities in the quality of and access to health care, barriers to health equity, and components of an effective social history as part of the individual’s medical-history-taking and physical examination.
Current and Future Applications of Gene Therapy, Stephan A. Grupp, MD, PhD, Children's Hospital of Philadelphia
Gene therapy has been investigated as a potential intervention in a number of diseases and/or disorders, including chronic neuropathic pain, melanoma, cardiovascular disease and cancer. This presentation will review the latest evidence-based practice guidelines surrounding gene therapies, as well as available safety and efficacy data surrounding its use in a variety of disease states.
Chronic Pain Is a Disease, Not a Symptom of Disease, Scott G. Pritzlaff, MD, Stanford University Pain Management Center
When pain becomes chronic, it is no longer merely a symptom, but a disease in itself. According to the National Health Interview Survey, an estimated 25.3 million adults in the United States suffer from chronic pain. This session will focus on what is new in the management of chronic pain and in what ways this field is evolving. The importance of interprofessional strategies to integrate pharmaceutical and nonpharmaceutical treatment options for chronic pain will be addressed, as well as the importance of improving communication with patients about chronic pain diagnosis and treatment.
Lunch Buffet (provided)
Satellite Symposia (optional; not affiliated with the Medical Director/Physician Leadership Forum)
Dessert Reception and Exhibit Hall Grand Opening
Medical Advances and Optimal Treatment Approaches for Inflammatory Bowel Disease, Dermot McGovern, MD, PhD, FRCP (Lon), Cedars-Sinai Medical Center
The Centers for Disease Control (CDC) estimate that 1 to 1.3 million people suffer from inflammatory bowel disease (IBD) in the United States. These patients often require long-term management involving steroids, maintenance therapy with immunomodulators and biologicals, and acute interventions. During this session, factors affecting the risk and course of IBD and the most updated protocols and guidelines for diagnosing and treating IBD will be discussed. New therapies targeting the immune process that are revolutionizing the treatment of IBD will also be presented.
Preventive Cardiovascular Care: What’s New? Haitham Ahmed, MD, MPH, Cleveland Clinic
Accumulating evidence has revealed that intestinal microbiota play an important role in human health and disease, including cardiovascular diseases. This session will discuss the roles of gut microbiota and focus on gut microbes as a factor and therapeutic target in cardiovascular disease. In addition, the latest guidelines for prevention and treatment of co-morbid conditions associated with cardiovascular disease will be reviewed.
Alzheimer’s: Is There Hope on the Horizon? Howard Feldman, MD, FRCP, University of California, San Diego
More than 5 million Americans are currently diagnosed with Alzheimer’s disease, making it the sixth leading cause of death in this country. However, health care providers are challenged with diagnosing Alzheimer’s disease and in discussing the diagnosis with patients and their families. A factor that leads to a delayed diagnosis is difficulty in distinguishing between normal signs of aging and the progressive dementia associated with Alzheimer’s disease. This session will describe the challenges of diagnosing Alzheimer’s disease, common clinical signs and symptoms, pharmaceutical and nonpharmaceutical interventions, and resources to optimize the management of patients with this disease.
Chronic Kidney Disease: Early and Effective Intervention and Evidence-based Guidelines for Optimal Management, Joseph Vassalotti, MD, National Kidney Foundation
Chronic kidney disease (CKD) is a significant public health problem in the United States and a major source of suffering and poor quality of life for those afflicted. It is responsible for premature death and demands a high economic price from both the private and public sectors. The prevalence of CKD is increasing, and more than 50 percent of adults 30–64 years old are projected to develop CKD over their lifetimes. Studies suggest that interdisciplinary management of CKD — such as pharmacist medication therapy management, risk stratification and early treatment — can improve patient outcomes. With a focus on early identification and intervention to lessen the burden of CKD, this session will review practice guidelines and the latest innovations for diagnosing, evaluating, and managing this disease. It will also cover new tools, such as CKD checklists, that may improve adherence to professional guidelines and care.
Networking Reception and Exhibits (provided)
Note: OptumHealth Education reserves the right to make any necessary changes to this program. Efforts will be made to keep presentations as scheduled. However, unforeseen circumstances may result in the substitution of faculty or content.
Last Updated: 10/09/2017